Loading...

The Grocery Store That Shrank Its Way to Prosperity

Published
28 Oct 25
Updated
20 Mar 26
Views
408
n/a
n/a
tripledub's Fair Value
n/a
Loading
1Y
-49.4%
7D
-2.1%

Author's Valuation

US$9619.5% undervalued intrinsic discount

tripledub's Fair Value

Last Update 20 Mar 26

Fair value Decreased 21%

Sprouts Farmers Market: Checking Back In

Last September I wrote up Sprouts at $108 and concluded, essentially, that the business was excellent and the price was not. Here is what has happened since.

The stock fell 22%. The business improved. These two facts are not in conflict. They're the opening act of what could eventually become a good investment, provided one is willing to wait for the price to catch up with the reality.

The Scorecard

Full-year 2025 was unambiguously strong. Revenue hit $8.81 billion, up 14%. Earnings per share came in at $5.31, a 42% increase. Operating cash flow reached $716 million, of which roughly $492 million converted to free cash flow after capital expenditures. The store count grew from 455 to 477: 37 new locations, all in the 23,000 square-foot format that has been the engine of Sprouts' capital efficiency. Private label penetration crept up from 24% to nearly 26%. Return on invested capital improved from the 17.8% we cited last time to 18.3%.

The balance sheet remains spotless: $257 million in cash, $82 million in long-term obligations, nothing drawn on a $600 million credit facility. Management deployed $472 million into share buybacks during the year, all funded from operations. No debt was incurred. No financial engineering was required.

By every operational measure, the business is in better shape than it was six months ago.

The Deceleration

The market, however, is not pricing the rearview mirror. It's pricing the windshield, and the view ahead has changed.

FY2025 comparable store sales grew 7.3%, a strong number in isolation, but a meaningful step down from the 10.9% pace in the first half that had investors excited. Q4 comps decelerated sharply to 1.6%. And management's guidance for 2026 is the most cautious since Jack Sinclair's turnaround began: full-year comps of -1% to +1%, with the first quarter expected between -3% and -1%.

EPS guidance of $5.28 to $5.44 landed 4-7% below analyst consensus of $5.68 to $5.69. Curtis Valentine, the CFO, cited "strong prior year comparisons and a dynamic macro environment." Translated from the corporate: the customers are tightening their belts, and we're lapping quarters that will be very hard to beat.

When I warned six months ago that the primary risk was growth deceleration, that was a forecast. It is now a fact.

What the Insiders Actually Did

Initial research reports, including my own early notes, flagged heavy insider selling in March 2026 as a red flag. I want to correct the record.

The actual SEC filings show something far more mundane. Several executives sold small blocks of stock totaling roughly 3,000 shares to cover tax withholding on vesting restricted stock units. CEO Sinclair's portion was about 1,052 shares, a 0.53% reduction in his position. These are automatic-style transactions that happen at every public company during vesting windows.

What the initial reports missed was the other side of the ledger. Two board directors, Joel Anderson and Kristen Blum, voluntarily bought a combined 5,725 shares on the open market in early March, putting roughly $440,000 of personal money into the stock at $76-77 per share. Open-market purchases by directors carry more signal than RSU tax sales by executives. Nobody buys $340,000 worth of stock at a 52-week low because their accountant told them to.

Net insider activity in March 2026 was modestly positive. Not a reason to buy, but it removes what had looked like a reason for concern.

Recalibrating the Valuation

My prior DCF put fair value near $122. That estimate was built on an assumption of mid-to-high single-digit comp growth continuing. Management has now explicitly told us that assumption was too generous, at least for the near term.

Updated for a lower growth trajectory (5% revenue CAGR after a flat 2026, free cash flow margins stabilizing at 6%), the base case fair value comes down to roughly $96. The bear case (competitive erosion, margin compression) lands at $65. The bull case (health trend reaccelerates, new stores outperform) reaches $125.

At $84.52, the stock trades about 12% below the base case. In September, at $108, it traded about 11% below the old base case of $122. In other words, the discount has barely moved: the stock got cheaper, but so did the estimate of what it's worth.

Twelve percent below fair value is not a compelling entry for a business entering its first negative-comp quarter. I'd want 35%, around $62 to $65, before committing capital. That price may come if Q1 2026 results confirm the deceleration, or if a broader market correction sweeps up consumer staples with everything else.

Where I Stand

Six months ago: hold and watch. Today: hold and set limit orders.

The business is better. The price is lower. The growth outlook is worse. The insider picture is more nuanced than it first appeared. The competitive threats haven't gone away, but they haven't materialized in the margins yet either.

Sprouts remains a genuinely well-run specialty grocer with unit economics that most retailers would envy. The management team has earned its credibility through disciplined execution and intelligent capital allocation. None of that has changed. What has changed is the market's willingness to pay a premium for it, and that repricing is still in progress.

I'm waiting for it to finish.

---

September 2025 vs. March 2026:

| Element | September 2025 | March 2026 |

|---------|----------------|------------|

| Revenue | $4.46B (H1) | $8.81B (FY) |

| Comps | 10.9% | 7.3% (FY25); guided -1% to +1% (FY26) |

| Store count | 455 | 477 |

| ROIC | 17.8% | 18.3% |

| Private label | 24% | ~26% |

| Share price | $108 | $84.52 |

| Forward P/E | 20-21x | ~16x |

| DCF fair value | $122 | $96 |

| Insider activity | N/A | Small RSU tax sales; director buying at lows |

| Stance | Hold and watch | Hold and set limit orders |

41 viewsusers have viewed this narrative update

In 2020, Jack Sinclair did something that most retail executives would consider career suicide. He took a chain of 30,000 square-foot grocery stores and decided to make them smaller. Not a little smaller. A full third smaller, down to 23,000 square feet, about half the size of a conventional supermarket. He ripped out the national brands, killed the deli counters, and rebuilt the whole thing around a farmer's market produce display in the middle of the floor.

Six years later, Sprouts Farmers Market has nearly tripled its earnings per share, carries zero net debt, and generates almost half a billion dollars a year in free cash flow. The smaller stores cost $3.8 million in cash to open, break even within the first year, and throw off low-to-mid 30% returns on invested capital by year five. You don't need an MBA to recognize those as extraordinary numbers. You just need a calculator and a willingness to read them twice.

The question, as always, is what to pay for that kind of quality. And right now, the answer is: not quite this much.

The Produce Section as Competitive Moat

Walk into a Sprouts and the first thing you notice is that it doesn't smell like a grocery store. It smells like a farmer's market. That's by design. Fresh produce sits at the center of the floor (not along the walls, not in a back corner) and roughly 55-60% of it is organic. The whole layout is engineered to make health-conscious shoppers feel like they've discovered something, like browsing a curated boutique rather than pushing a cart through aisles of Coca-Cola and Tide.

You won't find Coca-Cola or Tide at Sprouts. That's the strategic decision that makes everything else work. By refusing to stock the big national brands, Sprouts sidesteps the price wars that bleed conventional grocers dry. Walmart, Kroger, and Costco fight each other to the death over who can sell Coke for a penny less. Sprouts doesn't show up to that fight. Instead, it stocks attribute-driven products (plant-based, keto, paleo, non-GMO, gluten-free) and sells them to a customer who is willing to pay more for products aligned with how they want to eat.

The company calls this customer the "Health Enthusiast." It's roughly 15% of the U.S. grocery market. That sounds niche, and it is. But niche is exactly where the margin lives. Sprouts pulled a 38.8% gross margin in fiscal 2025. In grocery, where 30% is considered respectable, that number is exceptional.

The Arithmetic of a Good Business

I want to dwell on the financials for a moment, because they tell a story that the stock price has been too busy declining to acknowledge.

Fiscal 2025: $8.81 billion in revenue, up 14%. Operating cash flow of $716 million. After reinvesting $224 million (net of landlord reimbursements) into new stores and infrastructure, roughly $492 million flowed through as free cash flow. Diluted earnings per share hit $5.31, up 42% from the prior year.

The balance sheet carries $257 million in cash, $82 million in long-term obligations, and zero drawn on a $600 million revolving credit line. Net cash: roughly $176 million. In an industry where leverage is the norm and bankruptcy is a recurring character, this is a company that could fund its entire growth plan for the next two years from cash on hand and still have room to buy back stock.

Which is exactly what management is doing. A $1 billion buyback authorization was approved in August 2025. Of that, $472 million was deployed during the fiscal year: 4 million shares retired, funded entirely from free cash flow. When a business with no debt buys back its own shares at what appears to be cycle-low prices, it tells you something about how the people running the company think about capital allocation. They'd rather own more of their own business than do almost anything else with the money. That's a value investor's instinct operating inside a corporate boardroom.

The number I care about most is return on invested capital: 18.3%, up from 12.4% three years ago. The company's cost of capital runs around 7.3%, meaning every dollar of invested capital earns roughly two and a half times what it costs. That's the definition of economic value creation, and it's been improving every year since Sinclair's format redesign took hold.

A Thousand Stores on the Horizon

Sprouts currently operates 477 stores across 24 states. The plan is to open 40 or more this year, with a pipeline of over 140 approved sites and 95 executed leases. The long-range target is 1,000 to 1,400 stores nationwide.

Let that number settle for a moment. If the current unit economics hold ($3.8 million investment per store, breakeven in year one, 30%+ cash returns by year five) then each new store is essentially a small, self-funding franchise that pays for itself and then starts mailing checks back to headquarters. Multiply that by 500 additional locations and you have a very large compounding machine.

The company is also building out its own distribution network, targeting 80% of stores within 250 miles of a fresh distribution center. Self-distributing fresh meat and seafood, scheduled to deliver full margin benefits in 2026, should tighten inventory control and cut out middleman costs. These aren't glamorous initiatives. They're the plumbing of a retail operation. But plumbing is where margin lives.

Private label, branded "Sprouts," now accounts for nearly 26% of revenue. Trader Joe's, for context, is estimated at around 80%. The gap between 26% and, say, 35% represents years of higher-margin growth without opening a single new store. Every percentage point of private label penetration displaces a lower-margin branded product and drops almost entirely to the bottom line.

Where the Road Gets Narrow

So far I've been telling you the good news. Here's the rest.

Management has guided FY2026 comparable store sales at -1% to +1%, with the first quarter expected between -3% and -1%. This is the first flat-to-negative comp period since Sinclair transformed the business. EPS guidance of $5.28 to $5.44 came in 4-7% below what analysts expected, against a consensus of $5.68 to $5.69. The post-pandemic wave of health-conscious spending is receding, and the comparisons against 7-10% comp quarters from 2024 and 2025 are simply brutal.

I suspect this is cyclical rather than structural. The "Health Enthusiast" hasn't stopped caring about what she eats. She's adjusting her grocery budget after several years of elevated spending. But I'd be lying if I told you I was certain about the distinction, and the difference between cyclical and structural matters enormously when you're deciding what multiple to pay.

Competition is the slower-burning concern. Walmart, Kroger, and Amazon's Whole Foods are all expanding their organic and natural assortments. When the three largest food retailers in America decide your niche is interesting, the question isn't whether they'll compete. It's whether they'll compete effectively enough to compress your margins. Sprouts has advantages: the smaller format, the curated assortment, the treasure-hunt experience. But advantages in retail tend to erode gradually, and you don't always notice until the quarterly numbers confirm it.

Then there's geography. The 1,000-store vision requires Sprouts to succeed in the Midwest and Northeast, where it has minimal brand recognition and fewer natural allies in the local farming community. Every specialty retailer in history, every single one, has stumbled when expanding beyond its core territory. Some recover. Some don't. I'd rather watch the early innings of that geographic expansion from the sidelines than pay full price to participate.

On the insider front, the March 2026 picture is quieter than initial reports suggested. Several executives sold small blocks totaling roughly 3,000 shares to cover tax obligations on vesting RSUs, the kind of mechanical transaction that happens at every public company and tells you nothing. More noteworthy, two board directors, Joel Anderson and Kristen Blum, purchased a combined 5,725 shares on the open market at $76-77, committing about $440,000 of personal capital. When directors buy voluntarily at what looks like a trough, it's a modest vote of confidence. Not a thesis, but a data point.

The Gap Between Quality and Price

A ten-year discounted cash flow model using a 7.34% discount rate gives me three scenarios for what the business is worth today.

If the company grows revenue at roughly 5% annually after a flat 2026 and stabilizes free cash flow margins at 6%, the base case fair value is approximately $96 per share. If the health-conscious trend reaccelerates and new stores outperform, the bull case stretches to around $125. If Amazon triggers a price war in organic grocery and conventional grocers replicate the attribute-driven assortment, the bear case compresses to roughly $65.

The stock sits at $84.52. That's about 12% below my base case, which might sound like a discount but isn't much of one for a company entering its first negative-comp quarter. A disciplined approach would demand at least 35% below fair value, around $62 to $65, before the risk-reward tips decisively in the buyer's favor.

Here's the tension. At $182 last year, Sprouts was priced as though double-digit comps would continue indefinitely. At $84.52 today, it's priced as though the growth story might be over. Neither was correct. The truth is somewhere in between, and the stock is migrating slowly toward it.

I don't own shares yet. The business keeps compounding value. The stock keeps compounding my interest. Eventually those two trajectories will intersect at a price where patience gets rewarded. The limit orders are in place. I'm content to wait.

---

Key numbers at a glance:

| Metric | Value |

|--------|-------|

| Current price | $84.52 |

| FY2025 revenue | $8.81B (+14% YoY) |

| FY2025 comp store sales | 7.3% |

| FY2026 comp guidance | -1% to +1% |

| Free cash flow (FY2025) | ~$492M |

| Return on invested capital | 18.3% |

| Net cash position | ~$176M |

| Store count | 477 (target: 1,000+) |

| Private label penetration | ~26% |

| Base case fair value | $96 |

| Bull case fair value | $125 |

| Bear case fair value | $65 |

| Discount to base case | ~12% |

Have other thoughts on Sprouts Farmers Market?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

The user tripledub has a position in NasdaqGS:SFM. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

US$185.22
FV
58.3% undervalued intrinsic discount
10.85%
Revenue growth p.a.
49
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$90
FV
14.2% undervalued intrinsic discount
9.00%
Revenue growth p.a.
39
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative